Tetagam P Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Human tetanus Ig

Indications/Uses

Immediate post-exposure prophylaxis after tetanus prone injuries in patients who are not adequately vaccinated, whose immunization status is not known w/ certainty or w/ severe deficiency in Ab production. Therapy of clinically manifested tetanus.

Click to view Tetagam P detailed prescribing information

Dosage/Direction for Use

IM Adult & childn Prophylaxis of tetanus prone wounds 250 IU, may be increased to 500 IU. Extensive burns Administer 2nd inj of 250 IU after exudative phase of the burn has subsided (about 36 hr after onset of the burn). Therapy of clinically manifested tetanus 3,000-6,000 IU as single dose.

Click to view Tetagam P detailed prescribing information

Contraindications

Hypersensitivity to human tetanus Ig or human Ig.

Click to view Tetagam P detailed prescribing information

Special Precautions

Do not inj intravascularly. Anaphylactic reactions in IgA deficient patients. Observe patient for at least 20 min after administration.

Click to view Tetagam P detailed prescribing information

Use In Pregnancy & Lactation

Click to view Tetagam P detailed prescribing information

Adverse Reactions

Allergic reactions including fall in BP, dyspnoea, cutaneous reactions; chills, fever, headache, malaise, nausea, vomiting, arthralgia & moderate back pain; CV reactions if inadvertently injected IV; local reactions at the inj site (local pain, tenderness or swelling).

Click to view Tetagam P detailed prescribing information

Drug Interactions

May impair the efficacy of live attenuated virus vaccines eg, measles, rubella, mumps & varicella vaccines for a period of up to 3 mth. May result in misleading +ve test results in serological testing due to transitory rise of passively transferred Abs after inj. May interfere w/ some serological tests for red cell allo-Abs (eg, Coombs' test).

Click to view Tetagam P detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Tetagam P detailed prescribing information

Storage

View Tetagam P storage conditions for details to ensure optimal shelf-life.

Description

View Tetagam P description for details of the chemical structure and excipients (inactive components).

Action

View Tetagam P mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J06BB02 - tetanus immunoglobulin ; Belongs to the class of specific immunoglobulins. Used in passive immunizations.

Regulatory Classification

Presentation/Packing

Form

Tetagam P vaccine (inj) 250 IU/mL

Packing/Price

1 mL x 1's

Tetagam P

tetanus immunoglobulin

Manufacturer:

CSL Behring

Distributor:

Zuellig